Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor alpha.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/0AC15DF4.svg?ark=w1%2F20260515%2F0AC15DF4)](https://nobleid.org/work/w1/20260515/0AC15DF4)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors